RAPT Therapeutics announces $50M PIPE financing

May 25, 2022 8:50 AM ETRAPT Therapeutics, Inc. (RAPT)By: Preeti Singh, SA News Editor
  • RAPT Therapeutics (NASDAQ:RAPT) has announced a private placement financing of $50M.
  • The PIPE financing was secured from the sale of pre-funded warrants, to purchase up to 4M shares of common stock at a price per pre-funded warrant of $12.4999, to Redmile Group.
  • The transaction is expected to close on May 27, 2022.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.